EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals
EyePoint Pharmaceuticals told investors its Phase 3 wet AMD program was "on track" days before disclosing that DURAVYU missed the prespecified primary endpoint. SueWallSt notifies investors of a pending investigation into on behalf of EYPT investors who suffered losses. NEW YORK, Aug. 20,...
Covered in this story
What has happened since
- Eyepoint Inc is down 92.1% since this was published, 63 days ago.
- Advanced Micro Devices is up 8.2% since this was published, 63 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $EYPT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Eyepoint Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.